RNA G-四重复重编程与富含关氨酸的反意义寡核酸抑制了单胺氧化酶B的翻译
Marc-Antoine Turcotte1, Jean-Pierre Perreault1
1Department of Biochemistry and Functional Genomics, Cancer Research Institute, Université de Sherbrooke, Sherbrooke, Québec J1E 4K8, Canada.
ACS bio & med chem Au
|June 25, 2025
概括
研究人员在MAOB mRNA中发现了一种抑制翻译的RNA G-四重复 (rG4). 将这种rG4重新编程为富含G的反意义寡核酸 (G-ASOs) 特别减少了MAOB转换,为帕金森病提供了治疗策略.
科学领域:
- 分子生物学分子生物学
- RNA结构和功能 RNA结构和功能
- 神经科学是一个神经科学.
背景情况:
- 人类转录组具有RNA G-四重复 (rG4s) 的特征,通过核糖体停滞来调节基因表达,包括翻译.
- 在mRNA 5'未翻译区域 (5'UTRs) 中的正规rG4s可以阻碍翻译,这种机制与帕金森病 (PD) 等神经退行性疾病有关.
- 在非突变的治疗标中,如单胺氧化酶B (MAOB) 中,rG4s的作用仍然在很大程度上未被描述.
研究的目的:
- 为了识别和描述MAOB mRNA的5'UTR中的rG4.
- 研究调节这个rG4以控制MAOB翻译的方法.
- 探索针对rG4s治疗PD等疾病的治疗潜力.
主要方法:
- 在MAOB mRNA 5'UTR.中识别一个rG4.
- 在体外和细胞内测试以评估rG4转化抑制.
- 使用PhenDC3连接体稳定rG4.
- 使用富含G的反意义寡核酸 (G-ASOs) 重编程rG4,以改变其结构和功能.
主要成果:
- 在MAOB mRNA 5'UTR中发现了一种rG4,证明了转化抑制作用in vitro和in cellulo.
- 翻译抑制是由PhenDC3配体增强的.
- G-ASOs (DNA或2'OMe) 诱导了新的分子间rG4折叠,特别是减少了MAOB转化在体外和在纤维素中.
结论:
- 在MAOB mRNA 5'UTR中的rG4s可以调节以控制蛋白质合成.
- G-ASOs提供了一个针对性的方法来重编程rG4s,与连接体相比提供了特异性.
- 这种通过G-ASO调节rG4的策略为减少MAOB活动和潜在地缓解PD症状提供了一种新的治疗途径.
相关概念视频
Types of RNA
6.5K
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in regulating gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA Performs Diverse...
RNA Performs Diverse...
6.5K
Leaky Scanning
5.2K
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.2K
Experimental RNAi
6.3K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.3K
Eukaryotic Transcription Inhibitors
10.0K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
10.0K
Nonsense-mediated mRNA Decay
10.9K
The Upf proteins that carry out nonsense-mediated decay (NMD) are found in all eukaryotic organisms, including humans. Each protein has an individual role, but they need to work in collaboration. Upf1 is an ATP-dependent RNA helicase that unwinds the RNA helix. Because Upf1 can unwind any RNA, Upf2 and Upf3 are required to help Upf1 discriminate between nonsense and normal mRNAs.
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
10.9K
RNA Interference
26.5K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.5K


